Search Results - Robert E. Drolet

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Lessons from the rotenone model of Parkinson's disease

    Lessons from the rotenone model of Parkinson's disease by J. Timothy Greenamyre, Jason R. Cannon, Robert E. Drolet, Pier G. Mastroberardino

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    A highly reproducible rotenone model of Parkinson's disease

    A highly reproducible rotenone model of Parkinson's disease by Jason R. Cannon, Vı́ctor Tapias, Hye Mee Na, Anthony S. Honick, Robert E. Drolet, J. Timothy Greenamyre

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Non‐motor parkinsonian pathology in aging A53T α‐Synuclein mice is associated with progressive synucleinopathy and altered enzymatic function

    Non‐motor parkinsonian pathology in aging A53T α‐Synuclein mice is associated with progressive synucleinopathy and altered enzymatic function by Kaitlin Farrell, Sesha Krishnamachari, Ernesto Villanueva, Haiyan Lou, Tshianda N.M. Alerte, Eloise Peet, Robert E. Drolet, Ruth G. Perez

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells

    Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells by Marija Usenovic, Shahriar Niroomand, Robert E. Drolet, Lihang Yao, Renee C. Gaspar, Nathan G. Hatcher, Joel B. Schachter, John J. Renger, Sophie Parmentier‐Batteur

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease

    Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease by Sarah Jinn, Cornelis Blauwendraat, Dawn Toolan, Cheryl A. Gretzula, Robert E. Drolet, Sean M. Smith, Mike A. Nalls, Jacob Marcus, Andrew Singleton, David J. Stone

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation

    TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation by Sarah Jinn, Robert E. Drolet, Paige E. Cramer, Andus Hon-Kit Wong, Dawn Toolan, Cheryl A. Gretzula, Bhavya Voleti, Galya Vassileva, Jyoti Disa, Marija Tadin‐Strapps, David J. Stone

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease

    LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease by Emily M. Rocha, Briana R. De Miranda, Sandra L. Castro, Robert E. Drolet, Nathan G. Hatcher, Lihang Yao, Sean M. Smith, Matthew T. Keeney, Roberto Di Maio, Julia Kofler, Teresa G. Hastings, J. Timothy Greenamyre

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: